
Guangzhou Jointas Chemical Co., Ltd.
SZSE:002909.SZ
7.65 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 1,284.918 | 1,332.397 | 1,450.381 | 1,675.54 | 1,258.712 | 1,016.052 | 932.62 | 802.169 | 501.371 | 506.012 | 536.263 | 453.306 | 408.086 |
Cost of Revenue
| 959.745 | 999.438 | 1,138.702 | 1,323.015 | 865.865 | 658.442 | 703.044 | 567.982 | 308.254 | 316.276 | 361.908 | 315.08 | 293.791 |
Gross Profit
| 325.173 | 332.96 | 311.678 | 352.525 | 392.847 | 357.61 | 229.576 | 234.186 | 193.117 | 189.736 | 174.354 | 138.226 | 114.295 |
Gross Profit Ratio
| 0.253 | 0.25 | 0.215 | 0.21 | 0.312 | 0.352 | 0.246 | 0.292 | 0.385 | 0.375 | 0.325 | 0.305 | 0.28 |
Reseach & Development Expenses
| 54.038 | 65.627 | 60.98 | 69.219 | 52.952 | 37.763 | 34.737 | 27.349 | 8.89 | 12.511 | 16.635 | 18.975 | 15.028 |
General & Administrative Expenses
| 23.032 | 28.133 | 23.806 | 24.139 | 21.868 | 21.883 | 15.054 | 16.154 | 13.802 | 14.275 | 10.723 | 42.885 | 37.75 |
Selling & Marketing Expenses
| 64.381 | 76.109 | 124.672 | 129.472 | 112.101 | 142.044 | 125.292 | 104.101 | 78.109 | 68.721 | 55.698 | 40.293 | 27.995 |
SG&A
| 87.413 | 227.604 | 148.478 | 153.612 | 133.969 | 163.927 | 140.346 | 120.255 | 91.911 | 82.996 | 66.421 | 83.178 | 65.744 |
Other Expenses
| 165 | 26.604 | 51.731 | 49.109 | 43.945 | 38.712 | -1.084 | 0.218 | 2.072 | 2.181 | 0.772 | 0.371 | 0.653 |
Operating Expenses
| 311.711 | 319.836 | 261.188 | 271.94 | 230.865 | 240.403 | 198.87 | 172.073 | 133.09 | 124.069 | 108.8 | 85.246 | 67.857 |
Operating Income
| 13.461 | 13.124 | 51.127 | 85.178 | 137.294 | 103.628 | 27.04 | 53.389 | 51.265 | 59.05 | 38.823 | 43.713 | 39.927 |
Operating Income Ratio
| 0.01 | 0.01 | 0.035 | 0.051 | 0.109 | 0.102 | 0.029 | 0.067 | 0.102 | 0.117 | 0.072 | 0.096 | 0.098 |
Total Other Income Expenses Net
| -0.899 | -1.972 | -39.519 | -31.358 | -0.881 | -1.047 | -1.084 | 0.218 | 1.395 | 1.838 | 0.472 | 0.187 | -3.469 |
Income Before Tax
| 12.563 | 11.152 | 11.608 | 53.82 | 136.413 | 102.581 | 25.955 | 53.608 | 52.665 | 60.888 | 39.295 | 43.901 | 40.575 |
Income Before Tax Ratio
| 0.01 | 0.008 | 0.008 | 0.032 | 0.108 | 0.101 | 0.028 | 0.067 | 0.105 | 0.12 | 0.073 | 0.097 | 0.099 |
Income Tax Expense
| -6.709 | 0.904 | 1.44 | 3.125 | 23.648 | 16.89 | 7.213 | 8.365 | 9.972 | 11.934 | 11.672 | 7.815 | 7.37 |
Net Income
| 19.28 | 10.241 | 10.191 | 50.689 | 111.751 | 85.416 | 18.742 | 45.243 | 42.693 | 48.954 | 27.623 | 36.086 | 33.205 |
Net Income Ratio
| 0.015 | 0.008 | 0.007 | 0.03 | 0.089 | 0.084 | 0.02 | 0.056 | 0.085 | 0.097 | 0.052 | 0.08 | 0.081 |
EPS
| 0.049 | 0.028 | 0.027 | 0.14 | 0.34 | 0.26 | 0.057 | 0.17 | 0.17 | 0.2 | 0.14 | 0.15 | 0.13 |
EPS Diluted
| 0.049 | 0.028 | 0.027 | 0.14 | 0.34 | 0.26 | 0.056 | 0.17 | 0.17 | 0.2 | 0.14 | 0.15 | 0.13 |
EBITDA
| 103.742 | 99.761 | 85.057 | 109.054 | 180.359 | 132.637 | 50.124 | 72.65 | 64.398 | 73.743 | 49.041 | 57.641 | 48.838 |
EBITDA Ratio
| 0.081 | 0.075 | 0.059 | 0.065 | 0.143 | 0.131 | 0.054 | 0.091 | 0.128 | 0.146 | 0.091 | 0.127 | 0.12 |